omeprazole has been researched along with Gastric Outlet Obstruction in 5 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Gastric Outlet Obstruction: The hindering of output from the STOMACH into the SMALL INTESTINE. This obstruction may be of mechanical or functional origin such as EDEMA from PEPTIC ULCER; NEOPLASMS; FOREIGN BODIES; or AGING.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Intravenous pantoprazole is especially distinguished in its lack of clinically relevant drug interactions, and it requires no dosage adjustment for patients with renal insufficiency or with mild to moderate hepatic dysfunction." | 2.41 | Potential uses of intravenous proton pump inhibitors to control gastric acid secretion. ( Metz, DC, 2000) |
| "Primary lymph node gastrinomas are relatively rare in children and, to the best of our knowledge, have not previously been reported at this location." | 1.37 | Long-term follow-up of a child with primary lymph node gastrinoma and Zollinger-Ellison syndrome. ( Nazir, Z, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nazir, Z | 1 |
| Omura, N | 1 |
| Kashiwagi, H | 1 |
| Chen, G | 1 |
| Suzuki, Y | 1 |
| Yano, F | 1 |
| Aoki, T | 1 |
| Taskin, V | 1 |
| Gurer, I | 1 |
| Ozyilkan, E | 1 |
| Sare, M | 1 |
| Hilmioglu, F | 1 |
| Metz, DC | 1 |
| Reichart, M | 1 |
| Busch, OR | 1 |
| Bruno, MJ | 1 |
| Van Lanschot, JJ | 1 |
1 review available for omeprazole and Gastric Outlet Obstruction
| Article | Year |
|---|---|
Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Gastric Acid; Gastric Ac | 2000 |
1 trial available for omeprazole and Gastric Outlet Obstruction
| Article | Year |
|---|---|
Effect of Helicobacter pylori eradication on peptic ulcer disease complicated with outlet obstruction.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, | 2000 |
3 other studies available for omeprazole and Gastric Outlet Obstruction
| Article | Year |
|---|---|
Long-term follow-up of a child with primary lymph node gastrinoma and Zollinger-Ellison syndrome.
Topics: Abdominal Pain; Anti-Ulcer Agents; Child; Combined Modality Therapy; Diarrhea; Duodenal Ulcer; Follo | 2011 |
Establishment of surgically induced chronic acid reflux esophagitis in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Disease Models, Animal; Enzyme | 1999 |
Black esophagus: a view in the dark.
Topics: Acute Disease; Aged; Anti-Ulcer Agents; Esophageal Diseases; Esophagus; Gastric Outlet Obstruction; | 2000 |